# Sympathovagal Balance in Smoking Cessation

> **NCT01474265** · PHASE4 · COMPLETED · sponsor: **Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH** · enrollment: 85 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo
- **DRUG:** Nicorette TX

## Key facts

- **NCT ID:** NCT01474265
- **Lead sponsor:** Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2017-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01474265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01474265, "Sympathovagal Balance in Smoking Cessation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01474265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*